Search

Author/Creator Perry, Pamela

1. A cross-species approach to disorders affecting brain and behaviour. Issue 11 (November 2018)

Authors:
Devinsky, Orrin; Boesch, Jordyn; Cerda-Gonzalez, Sofia; Coffey, Barbara; Davis, Kathryn; Friedman, Daniel; Hainline, Brian; Houpt, Katherine; Lieberman, Daniel; Perry, Pamela; Prüss, Harald; Samuels, Martin; Small, Gary; Volk, Holger; Summerfield, Artur; Vite, Charles; Wisniewski, Thomas; Natters...
Journal:
Nature reviews
Issue:
Volume 14:Issue 11(2018)
Page Start:
677
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores. Issue 3 (June 2017)

Authors:
Ismail, Zahinoor; Peters-Strickland, Timothy; Miguelez, Maia; Baker, Ross A.; Hertel, Peter; Eramo, Anna; Jin, Na; Perry, Pamela; Sanchez, Raymond; McQuade, Robert D.; Kane, John M.
Journal:
Journal of clinical psychopharmacology
Issue:
Volume 37:Issue 3(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial. Issue 10369 (17th December 2022)

Authors:
Krystal, John H; Kane, John M; Correll, Christoph U; Walling, David P; Leoni, Matthew; Duvvuri, Sridhar; Patel, Shrinal; Chang, Ih; Iredale, Philip; Frohlich, Lillian; Versavel, Stacey; Perry, Pamela; Sanchez, Raymond; Renger, John
Journal:
Lancet
Issue:
Volume 400:Issue 10369(2022)
Page Start:
2210
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗